Shanghai Allist Pharmaceuticals Statistics

Total Valuation

Shanghai Allist Pharmaceuticals has a market cap or net worth of CNY 24.04 billion. The enterprise value is 21.01 billion.

Market Cap	24.04B
Enterprise Value	21.01B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Sep 5, 2024

Share Statistics

Shanghai Allist Pharmaceuticals has 450.00 million shares outstanding. The number of shares has decreased by -0.28% in one year.

Current Share Class	n/a
Shares Outstanding	450.00M
Shares Change (YoY)	-0.28%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	11.39%
Owned by Institutions (%)	16.95%
Float	206.77M

Valuation Ratios

The trailing PE ratio is 18.54 and the forward PE ratio is 18.25.

PE Ratio	18.54
Forward PE	18.25
PS Ratio	7.50
PB Ratio	4.94
P/TBV Ratio	n/a
P/FCF Ratio	19.72
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.86, with an EV/FCF ratio of 17.23.

EV / Earnings	16.20
EV / Sales	6.56
EV / EBITDA	15.86
EV / EBIT	16.51
EV / FCF	17.23

Financial Position

The company has a current ratio of 6.96, with a Debt / Equity ratio of 0.00.

Current Ratio	6.96
Quick Ratio	6.21
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.00
Interest Coverage	9,478.31

Financial Efficiency

Return on equity (ROE) is 30.48% and return on invested capital (ROIC) is 18.69%.

Return on Equity (ROE)	30.48%
Return on Assets (ROA)	16.91%
Return on Capital (ROIC)	18.69%
Revenue Per Employee	3.07M
Profits Per Employee	1.24M
Employee Count	1,044
Asset Turnover	0.68
Inventory Turnover	3.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.84% in the last 52 weeks. The beta is 0.55, so Shanghai Allist Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+50.84%
50-Day Moving Average	51.27
200-Day Moving Average	51.85
Relative Strength Index (RSI)	50.06
Average Volume (20 Days)	7,157,224

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Allist Pharmaceuticals had revenue of CNY 3.20 billion and earned 1.30 billion in profits. Earnings per share was 2.88.

Revenue	3.20B
Gross Profit	3.04B
Operating Income	1.27B
Pretax Income	1.42B
Net Income	1.30B
EBITDA	1.32B
EBIT	1.27B
Earnings Per Share (EPS)	2.88

Full Income Statement

Balance Sheet

The company has 3.03 billion in cash and 1.57 million in debt, giving a net cash position of 3.03 billion or 6.73 per share.

Cash & Cash Equivalents	3.03B
Total Debt	1.57M
Net Cash	3.03B
Net Cash Per Share	6.73
Equity (Book Value)	4.86B
Book Value Per Share	10.81
Working Capital	3.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.45 billion and capital expenditures -230.05 million, giving a free cash flow of 1.22 billion.

Operating Cash Flow	1.45B
Capital Expenditures	-230.05M
Free Cash Flow	1.22B
FCF Per Share	2.71

Full Cash Flow Statement

Margins

Gross margin is 94.86%, with operating and profit margins of 39.73% and 40.47%.

Gross Margin	94.86%
Operating Margin	39.73%
Pretax Margin	44.34%
Profit Margin	40.47%
EBITDA Margin	41.27%
EBIT Margin	39.73%
FCF Margin	38.05%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.94%.

Dividend Per Share	0.50
Dividend Yield	0.94%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	22.56%
Buyback Yield	0.28%
Shareholder Yield	1.21%
Earnings Yield	5.39%
FCF Yield	5.07%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Allist Pharmaceuticals has an Altman Z-Score of 24.91.

Altman Z-Score	24.91
Piotroski F-Score	n/a